𝓨𝓪𝓼𝓪𝓻 𝓗𝓪𝓶𝓶𝓸𝓻

Some call us Arabs, some call us Africans, and some call us Afro-arab... Being Sudanese is not about ethnicity, it's all about the values that we embrace, love we share, ethics and values embroided to our souls. #SudanProtests #SudanUprising #السودان

هجوم جديد على مرافق الرعاية الصحية في #السودان. مقتل 64 شخصا على الأقل، بينهم 13 طفلا وممرضتان وطبيب وعدد من المرضى في هجوم على مستشفى الضعين التعليمي في شرق دارفور، أدى أيضا إلى إصابة 89 شخصا، بينهم 8 من العاملين في المجال الصحي. news.un.org/ar/story/2026/…

@ChandrakanthMv Is it time to re-evaluate SOC for primary site LCT? While a single Phase II isn’t definitive, the cumulative data is mounting. We must ask: I-Who benefits most in the combo-therapy era? II-Are we over-treating our best responders? III-Should we reserve this for oligopersistence?

NorthStar trial 🌟 Osimertinib + LCT vs osimertinib alone PFS: 25.4 vs 17.0 mo HR 0.60 (p=0.02) Not just oligometastatic—benefit seen even beyond 👉 Target residual disease, delay resistance #MVOnco #Oncology #LungCancer #EGFR

Day 1 at #ASCOAIOM 🇮🇹 A full day immersed in clinical study design and the intricacies of trials and phases! Inspired by the great talks and discussion sessions :) Grateful to have been selected for the workshop! @AIOMtweet @AiomFondazione @ASCOPost @ASCO @HemOncMiami @SylvesterCancer

Don't Forget Sudan 🇸🇩 Talk about Sudan, the world’s worst displaced and humanitarian crisis 🇸🇩

@laiaaas @AASLDFoundation @EASLnews @APandT @UHNTransplant

It is finally out!🎉 Please take a look to our work on ICI prior to LT: ✅safety with 50d of WO ❌no differences in rejection rates with a non ICI population (PSM 1:3) More to come soon! @AASLDFoundation @EASLnews @APandT @UHNTransplant onlinelibrary.wiley.com/doi/10.1111/ap…

Out today! My latest guest is Dr Thomas Wright of the Brookings Institution and former member of Pres Biden National Security Council. podcasts.apple.com/ie/podcast/sec…

In Galway last year, 1,332 people were diagnosed with cancer and 531 people sadly died. I raised the financial burden that comes with a diagnosis, from lost income to added family pressures and asked what supports are being considered. (1/2)@IrishCancerSoc

Number Needed to Treat | New England Journal of Medicine - what a great editorial! nejm.org/doi/full/10.10…

pCR after neoadjuvant chemotherapy has long been considered a strong prognostic marker. But adding ultra-sensitive ctDNA changes the picture. In the PREDICT-DNA trial (NeXT Personal @PersonalisInc ), ctDNA-negative patients among non-pCR cases showed outcomes comparable to pCR. @JCO_ASCO Small sample size—but a highly impactful finding. ascopubs.org/doi/10.1200/JC…

Eid Mubark

Peace, love, and light. Eid Mubarak.

Eid Mubarak! 🌟 Wishing you and your loved ones a blessed celebration filled with love, laughter, and zero worries. May Allah accept our fasts and prayers

Managing dermatologic toxicities may look easy in trial settings, but not in the real world. At ILCS 2025, @tnewsomdavis reminded the audience that most hospitals don’t have instant access to dermatology teams. His message: treatments must be practical and manageable for the many, not just for specialized centers. Watch the discussion ⬇️ lungsummit.org/targeted-thera…

🩺 Sex during neutropenia — what should we tell patients? JCO Oncology Practice: • ❤️‍🩹 Sexual health remains important for quality of life during cancer treatment • 📉 Evidence for strict sexual restrictions in neutropenia is limited • 🤝 Stable monogamous partners: condoms not routinely required if partner healthy • ⚠️ Avoid anal sex/fecal exposure, new partners, or sex during severe mucositis • 🚿 Gentle hygiene is sufficient; over-washing may harm mucosa • 💊 Condoms may be used briefly after chemotherapy to protect partners from drug exposure 💡 Takeaway: counseling should be individualized and evidence-informed, not based on outdated blanket restrictions. 📄 ascopubs.org/doi/10.1200/OP… #HemOnc #Neutropenia #CancerCare #QualityOfLife @IMG_Oncologists @oncodaily @HemOncFellows

90% من مشاكل تحليل البيانات تبدأ من اختيار الاختبار الاحصائي الخطأ كوب قهوتك وتابع معي ☺️🌻

Perioperative immunotherapy in resectable NSCLC — which trial leads? KEYNOTE-671 CheckMate-77T AEGEAN Simple comparison 👇 • All improve EFS • Only KEYNOTE-671 shows OS benefit • Higher pCR with chemo-IO #MVOnco #LungCancer

Suicide is now the LEADING cause of death for US medical residents. We are losing 500 physicians a year. That is an entire med school class. Stop demanding "resilience" from doctors and start fixing the system. Tie executive bonuses to wellness, not just RVUs. Link to the recent episode is in the comments 👇

In EGFRm post osi, 2nd liner sac-TMT showed 8.3 vs 4.3 in Chemo arm. All subgroups showed benefit. ORR 60%. More stomatitis. Great results ! Published @NEJM #ESMO25 congrat to the authors!!

I collected every NotebookLM prompt that went viral on Reddit, X, and founder communities. Most people are using it like a glorified PDF reader. These 20 prompts turn it into a research weapon. (founders are hiding these) 👇